Form 4: ADC Therapeutics Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Director Robert Azelby sold 6,995 common shares of ADC Therapeutics SA on June 17, 2024, to cover tax withholding obligations related to the vesting and settlement of restricted share units.
Summary
- On June 17, 2024, Robert Azelby, a director of ADC Therapeutics SA, sold 6,995 common shares of the company.
- The shares were sold at a price of $2.89 per share.
- The transaction was executed to cover tax withholding obligations associated with the vesting and settlement of restricted share units.
- Following the transaction, Azelby directly owns 53,005 common shares.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation for company directors and officers.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder perception, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of the share sale transaction. |
| 06/18/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.